LifeVantage to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
LifeVantage (Nasdaq: LFVN), a health and wellness company focused on cellular health, has announced its participation in the upcoming Lytham Partners Fall 2025 Investor Conference. The virtual event will feature President and CEO Steve Fife and CFO Carl Aure, who will conduct investor meetings and deliver a presentation on September 30, 2025, at 11:00 a.m. ET.
Investors can access the live webcast through the company's Investor Relations website, with a replay available after the event.
LifeVantage (Nasdaq: LFVN), una società di salute e benessere focalizzata sulla salute cellulare, ha annunciato la sua partecipazione al prossimo Lytham Partners Fall 2025 Investor Conference. L'evento virtuale vedrà il presidente e CEO Steve Fife e il CFO Carl Aure, che terranno incontri con gli investitori e presenteranno il 30 settembre 2025 alle 11:00 ET.
Gli investitori potranno seguire la diretta streaming sul sito di Investor Relations dell'azienda, con una replica disponibile dopo l'evento.
LifeVantage (Nasdaq: LFVN), una empresa de salud y bienestar centrada en la salud celular, ha anunciado su participación en la próxima Conferencia de Inversores de Otoño 2025 de Lytham Partners. El evento virtual contará con el presidente y CEO Steve Fife y el director financiero Carl Aure, quienes realizarán reuniones con inversores y presentarán el 30 de septiembre de 2025 a las 11:00 a.m. hora del Este. Los inversores podrán acceder al webcast en vivo a través del sitio web de Relaciones con Inversores de la empresa, con una repetición disponible después del evento.
LifeVantage (Nasdaq: LFVN)은 세포 건강에 초점을 맞춘 건강 및 웰빙 회사로, 다가오는 Lytham Partners Fall 2025 Investor Conference에 참여한다고 발표했습니다. 가상 행사는 사장 겸 최고경영자 Steve Fife와 최고재무책임자 Carl Aure가 참석하여 투자자 미팅을 진행하고 2025년 9월 30일 동부 표준시 오전 11시에 프리젠테이션을 진행합니다.
투자자들은 회사의 Investor Relations 웹사이트를 통해 생중계에 접속할 수 있으며, 이벤트 후에 재방송이 제공됩니다.
LifeVantage (Nasdaq: LFVN), une société de santé et de bien-être axée sur la santé cellulaire, a annoncé sa participation à la prochaine Conférence des investisseurs d’automne 2025 de Lytham Partners. L’événement virtuel réunira le président-directeur général Steve Fife et le directeur financier Carl Aure, qui mèneront des entretiens avec les investisseurs et présenteront le 30 septembre 2025 à 11h00 HE.
Les investisseurs peuvent accéder à la diffusion en direct via le site Web des relations investisseurs de l’entreprise, avec une rediffusion disponible après l’événement.
LifeVantage (Nasdaq: LFVN), ein Gesundheits- und Wellness-Unternehmen mit Schwerpunkt auf zellulärer Gesundheit, hat seine Teilnahme an der bevorstehenden Lytham Partners Fall 2025 Investor Conference angekündigt. Die virtuelle Veranstaltung wird Präsident und CEO Steve Fife und CFO Carl Aure präsentieren, die Investorentreffen abhalten und am 30. September 2025 um 11:00 Uhr Ostzeit eine Präsentation halten.
Investoren können über die Website des Investor Relations-Teams des Unternehmens auf die Live-Übertragung zugreifen; eine Wiederholung wird nach der Veranstaltung verfügbar sein.
LifeVantage (Nasdaq: LFVN)، شركة صحة ولياقة تركز على الصحة الخلوية، أعلنت عن مشاركتها في مؤتمر المستثمرين خريف 2025 من ليذام بارتنرز القادم. الحدث الافتراضي سيضم الرئيس التنفيذي والعضو المنتدب ستيف فايب والمدير المالي كارل أور، الذين سيجرون اجتماعات مع المستثمرين ويقدمون عرضاً في 30 سبتمبر 2025، الساعة 11:00 صباحاً بتوقيت شرق الولايات المتحدة.
يمكن للمستثمرين الوصول إلى البث المباشر من خلال موقع علاقات المستثمرين الخاص بالشركة، مع وجود إعادة بث متاحة بعد الحدث.
LifeVantage (Nasdaq: LFVN)，一家专注于细胞健康的健康与保健公司，已宣布参加即将举行的 Lytham Partners Fall 2025 Investor Conference。此次虚拟活动将由 总裁兼首席执行官 Steve Fife 与 首席财务官 Carl Aure 出席，他们将进行投资者会谈并于 2025年9月30日美国东部时间上午11:00进行演示。
投资者可以通过公司投资者关系网站访问现场直播，活动结束后提供回放。
- None.
- None.
SALT LAKE CITY, Sept. 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the Lytham Partners Fall 2025 Investor Conference, to be held virtually September 30, 2025.
Mr. Fife and Mr. Aure will meet with investors and present at approximately 11:00 a.m. Eastern Time on Tuesday, September 30, 2025. A live webcast of their presentation will be accessible on the News & Events section of the Company’s Investor Relations website at https://lifevantage.gcs-web.com/ or directly here. A replay of the webcast will be archived and can be accessed on the Company’s website.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
FAQ
When is LifeVantage (LFVN) presenting at the Lytham Partners Fall 2025 Conference?
Who will represent LifeVantage (LFVN) at the Lytham Partners Conference?
How can investors access the LifeVantage (LFVN) Lytham Partners conference presentation?
What type of company is LifeVantage (LFVN)?
